Wedbush Downgrades Infinity Pharma To Underperform, Slashes Target To $3
March 22, 2016 at 13:31 PM EDT
Wedbush’s David M. Nierengarten downgraded the rating for Infinity Pharmaceuticals Inc. (NASDAQ: INFI) from Neutral to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.